Table 2 Follow-up, recurrence, and survival after LAVH ± LAE compared with laparotomy ± LAE for early endometrial cancer

[47]

56

Three-year survival and recurrence rates similar those of the abdominal approach

[48]

221/45

No difference with regard to recurrence or survival between groups (median follow-up 33.6 months)

[49]

100/86

Similar 2-year and 5-year estimated recurrence-free survival rates as well as overall survival rates

[18]

52/46

No difference in overall and recurrence-free survival between LAVH and laparotomy (follow-up 0–67 months)

[10]

3

Case reports on vaginal cuff recurrences after LAVH

[50]

47/31

Five-year survival rate similar that for laparotomy (94.7% FIGO I)

[39]

226/284

Patterns of recurrence similar in both groups (total laparoscopic vs. total abdominal hysterectomy; median follow-up 29.4 months)

[51]

63/59

Disease-free and overall survival similar in both groups (median follow-up 44 months, range 5–96 months)

[42]

41/36

Retrospective study, no differences in recurrence and survival rates

[43]

74/168

Three-year recurrence-free survival rates were similar: 97.5% vs. 98.6% respectively

[52]

19/94

No significant differences for disease-free and overall survival (total laparoscopic vs. total abdominal hysterectomy)

[44]

38/37

No significant difference in disease recurrence between the two groups

[53]

45/136

No statistically significant differences in disease-free survival and recurrence rate between groups